Search

In Stock

Buy Cibinqo (abrocitinib) Online

DISEASE INDICATIONS: Atopic Dermatitis

MANUFACTURER: Pfizer Limited

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Pharmaceuticals and Medical Devices Agency (PMDA)

Medicines & Healthcare products Regulatory Agency (MHRA)

Cibinqo (abrocitinib) is a prescription medicine used to treat adults and children 12 years of age and older with moderate-to-severe atopic dermatitis (eczema) that did not respond to other treatment and is not well controlled with prescription medicines, including biologics, or when they cannot be tolerated.

From $1,287.82

Clear
Compare

Cibinqo (abrocitinib) is a prescription medicine used to treat adults and children 12 years of age and older with moderate-to-severe atopic dermatitis (eczema) that did not respond to other treatment and is not well controlled with prescription medicines, including biologics, or when they cannot be tolerated.

Description: Cibinqo is a small molecule Janus kinase 1 (JAK1) inhibitor. JAK1 is a signaling enzyme that plays a role in the inflammatory and immune response. By blocking JAK1, Cibinqo helps to reduce inflammation and itching in eczema.

Uses: Cibinqo is used to treat adults and children 12 years of age and older with moderate-to-severe eczema that did not respond to other treatment and is not well controlled with prescription medicines, including biologics, or when they cannot be tolerated.

Storage Conditions: Cibinqo tablets should be stored at room temperature (68°F to 77°F) in their original container.

Mechanism of action: Cibinqo works by blocking the action of JAK1, a signaling enzyme that plays a role in the inflammatory and immune response. By blocking JAK1, Cibinqo helps to reduce inflammation and itching in eczema.

How to use: Cibinqo is taken once a day by mouth, with or without food. The recommended dosage is 100 mg for most adults. If an adequate response is not achieved after 12 weeks, the dosage may be increased to 200 mg. Cibinqo should be discontinued if an adequate response is not seen after dosage increase to 200 mg once daily.

Important Safety Information: Cibinqo can cause serious side effects, including:

  • Serious infections: Cibinqo can weaken your immune system, making you more susceptible to infections.
  • Allergic reactions: Cibinqo can cause severe allergic reactions, including anaphylaxis.
  • Blood clots: Cibinqo may increase your risk of blood clots.
  • Liver damage: Cibinqo can cause liver damage.

Indications: Cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis (eczema) in adults and children 12 years of age and older who have not responded to other systemic therapies or who cannot tolerate other systemic therapies.

Precautions: Cibinqo should be used with caution in patients with:

  • Active infections
  • A history of allergic reactions
  • A history of blood clots
  • Liver disease
  • Kidney disease
  • HIV/AIDS

Interactions: Cibinqo can interact with other medications, including:

  • Live vaccines
  • Immunosuppressants
  • Medications that can increase the risk of blood clots
  • Medications that can damage the liver

Contraindications: Cibinqo is contraindicated in patients with:

  • A known allergy to abrocitinib
  • Active tuberculosis
  • Severe active infections

Overdose: There is no specific antidote for overdose of Cibinqo. In case of overdose, supportive care should be provided.

Side effects: The most common side effects of Cibinqo include:

  • Upper respiratory tract infections
  • Headache
  • Nausea
  • Diarrhea
  • Abdominal pain
  • Increased liver enzymes

Less common side effects include:

  • Serious infections
  • Allergic reactions
  • Blood clots
  • Liver damage
  • Decreased white blood cell count
  • Decreased platelet count
  • Decreased neutrophil count
  • Decreased lymphocyte count
  • Increased cholesterol
  • Increased triglycerides
  • Increased blood sugar
  • Hypoglycemia
  • High blood pressure
  • Low blood pressure
  • Fatigue
  • Dizziness
  • Rash
  • Itching
  • Hair loss
  • Muscle pain
  • Joint pain
  • Back pain
  • Insomnia
  • Anxiety
  • Depression
  • Vision changes

If you experience any of these side effects, talk to your doctor.

Please note: This is not a complete list of all of the potential side effects of Cibinqo. For more information, please see the full prescribing information.

Package

28 tablets of 50 mg, 28 tablets of 100 mg, 28 tablets of 200 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Skilarence (dimethyl fumarate) Online

From $93.21
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Almirall, S.A. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Skilarence (dimethyl fumarate) is a prescription medication used to treat moderate to severe plaque psoriasis in adults. It is an oral medication that works by suppressing the immune system and reducing inflammation.

Buy Takhzyro (lanadelumab) Online

$14,055.70
(0 Reviews)
DISEASE INDICATIONS: Hereditary angioedema (HAE) MANUFACTURER: Shire Pharmaceuticals USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Takhzyro (lanadelumab) is a prescription medication used to prevent attacks of hereditary angioedema (HAE) in people 2 years of age and older. HAE is a rare genetic disorder that causes episodes of swelling in the face, throat, abdomen, hands, and feet. These episodes can be life-threatening.

Buy Cibinqo (abrocitinib) Online

From $1,287.82
(0 Reviews)
DISEASE INDICATIONS: Atopic Dermatitis MANUFACTURER: Pfizer Limited USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Medicines & Healthcare products Regulatory Agency (MHRA) Cibinqo (abrocitinib) is a prescription medicine used to treat adults and children 12 years of age and older with moderate-to-severe atopic dermatitis (eczema) that did not respond to other treatment and is not well controlled with prescription medicines, including biologics, or when they cannot be tolerated.

Buy Adbry (tralokinumab-ldrm) Online

$1,283.00
(0 Reviews)
DISEASE INDICATIONS: Atopic Dermatitis MANUFACTURER: Leo Pharma USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Adbry (tralokinumab-ldrm) is a fully human monoclonal antibody that neutralizes the activity of interleukin-13 (IL-13), a cytokine that plays a key role in the pathogenesis of atopic dermatitis. Adbry is approved for the treatment of moderate-to-severe atopic dermatitis (AD) in adults and adolescents 12 years of age and older.

Buy Zoryve (roflumilast) Online

$1,026.40
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Arcutis Biotherapeutics, Inc. USAGE: Cutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Zoryve (roflumilast) is a topical cream used to treat plaque psoriasis in adults and children 12 years of age and older. It works by blocking an enzyme called phosphodiesterase 4 (PDE4), which plays a role in inflammation.

Buy Ilumya (tildrakizumab) Online

(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Almirall, S.A. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Ilumya (tildrakizumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the p19 subunit of interleukin-23 (IL-23), a cytokine that plays a key role in the development and progression of psoriasis.

Buy Spevigo (spesolimab-sbzo) Online

(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Boehringer Ingelheim USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Spevigo (spesolimab-sbzo) is a prescription medication used to treat generalized pustular psoriasis (GPP) flares in adults. GPP is a rare autoinflammatory skin disease that can cause painful pustules (blisters) to form all over the body. Spevigo is the first FDA-approved treatment for GPP flares.

Back to Top
Product has been added to your cart